Johnson & johnson vaccine

The Food and Drug Administration strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine on Thursday due to the ongoing risk of rare but serious blood clots

U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots. The Food and Drug Administration said Thursday the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. The decision is the latest restriction to hit the company’s vaccine,...

A local doctor spoke to NBC Connecticut about what it means that the Johnson & Johnson shot is not the preferred vaccine of the CDC.

U.S. health advisers recommended the Johnson & Johnson COVID-19 vaccine booster for ages 18 and older at least two months after a primary dose.

U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus.

The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine

Johnson & Johnson submitted data to the Food and Drug Administration to receive emergency use authorization for its COVID-19 vaccine booster shots.

Who is eligible for a COVID vaccine booster shot and when following the latest update from the Centers for Disease Control and Prevention?

The U.S. death toll from COVID-19 is now over 675,000, surpassing the 1918 flu as the deadliest pandemic in the nation’s history. The record comes as leaders are pleading with unvaccinated adults to get their shots, while already vaccinated adults are wondering about booster shots to boost their immune response. Dr. Alok Patel weighs in.

Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response

Dr. Ulysses Wu, the system director for infectious diseases at Hartford Healthcare, explains what you need to know about the J&J booster vaccine.

Johnson & Johnson announced the results based on the two Phase 1/2 studies Wednesday.

The U.S. government’s top infectious disease expert, Dr. Anthony Fauci, says he’s hopeful that the Food and Drug Administration will give full approval to the coronavirus vaccine by month’s end.

So far, the “variant of interest” has been detected in 29 countries, and it may spread more quickly than milder versions of the coronavirus.

The U.S. Food and Drug Administration (FDA) put out a warning about the Janssen (Johnson & Johnson) COVID-19 vaccine after about 100 cases of a nerve condition were identified in people two weeks after inoculation. The nerve condition is called Guillain-Barre Syndrome or GBS. The body’s immune system damages nerve cells, causing muscle weakness or paralysis in the most...

The CDC confirmed Monday that about 100 cases of Guillain-Barré syndrome, a rare neurological disorder, were found in people who had received the Johnson & Johnson vaccine.

Hartford Healthcare is gearing up to resume giving out the Johnson & Johnson COVID-19 vaccine. “We’re excited to be able to get back to doing that,” said Dr. James Cardon, Hartford Healthcare Executive Vice President. Recently the CDC and FDA announced a nationwide hold was lifted after 11 days. That came amid reports of rare but severe blood clots in…

The Johnson & Johnson COVID-19 vaccine is back in the mix again. It was put on pause a little less than two weeks ago when at least six women had rare blood clots after getting the shot and one of them died.

After the CDC and FDA announced on Friday that the pause on the Johnson & Johnson vaccine would be lifted, CDC director Rochelle Walensky vouched for its safety and efficacy despite extremely rare serious side effects. “The [Johnson & Johnson vaccine] is an important vaccine offering key advantages, including its single-dose option and its viability when the supply chain may...